Professor Adam Frampton is a Consultant General and Hepato-Pancreato-Biliary (HPB) Surgeon based in Surrey and London. His NHS base is the Royal Surrey NHS Foundation Trust, Guildford, Surrey.

He is a specialist in treating hernias and gallstones, as well as benign and cancerous disorders of the liver, pancreas, gallbladder and biliary-tract.

Professor Frampton's interests include minimally invasive surgery, acute/chronic pancreatitis, complex gallstone disease, bile duct stones, gallbladder polyps, liver cysts, pancreatic cystic lesions, pancreatic cancer, liver tumours / metastases, neuroendocrine tumours and abnormal liver function tests/jaundice.

He qualified from Imperial College London in 2003 and completed his specialist training on the South-West London rotation. He advanced his surgical skills training in laparoscopic/robotic HPB surgery at the Hammersmith and Royal Marsden Hospitals, and in liver transplantation at the Royal-Free Hospital, London.

Professor Frampton is a well-recognised ‘surgical scientist’ and is an active researcher alongside his clinical practice. He was awarded a PhD from Imperial in 2013 for his work on pancreatic cancer. He was also awarded the distinguished Hunterian Professorship by the Royal College of Surgeons of England in 2018. 

He is currently tenured Assoc. Professor in Surgical Oncology and Head of Oncology at the University of Surrey where he leads a translational research laboratory group and supervises BSc, MSc, MD and PhD students.

His primary aim is to develop cutting-edge research and translate findings into patient benefits, using an evidence-based approach.